Telix Pharmaceuticals Limited (TLX.AX)
AUD 25.67
(-0.27%)
AUD 25.67
(-0.27%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 23.88 Million | -63.97 Million | -59.32 Million | 1.96 Million | -23.33 Million | -20.74 Million |
| Net Income | 5.21 Million | -104.07 Million | -80.51 Million | -44.88 Million | -27.86 Million | -13.82 Million |
| Depreciation & Amortization | 6.92 Million | 5.37 Million | 5.17 Million | 4.88 Million | 4.23 Million | 6968.00 |
| Deferred income taxes | -8.78 Million | -13.37 Million | -14.19 Million | -10.85 Million | -10.3 Million | -17.19 Million |
| Stock-based compensation | 8.78 Million | 8.11 Million | 1.32 Million | 2.34 Million | 1.26 Million | 712 Thousand |
| Change in working capital | -33.5 Million | -1 Million | -2.63 Million | 31.81 Million | -361 Thousand | -4.26 Million |
| Other non-cash items | 45.25 Million | 41 Million | 31.51 Million | 18.66 Million | 9.69 Million | 13.82 Million |
| Investing Cash Flow | -25.48 Million | -16.99 Million | -2.72 Million | -1.09 Million | -468 Thousand | -2.69 Million |
| Investments in PPE | -10.79 Million | -13.86 Million | -1.33 Million | -322 Thousand | -468 Thousand | - |
| Acquisitions | - | -973 Thousand | - | -322 Thousand | - | -2.69 Million |
| Investment purchases | -13.15 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -1.54 Million | -2.16 Million | -1.38 Million | -447 Thousand | -65 Thousand | - |
| Financing Cash Flow | 10.18 Million | 174.96 Million | 2.84 Million | 34.11 Million | 42.72 Million | -869.35 Thousand |
| Debt repayment | -5.75 Million | -3 Million | -340 Thousand | -402 Thousand | -1.16 Million | -869.35 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -7.81 Million | - | -130 Thousand | - | - |
| Common Stock Issuance | 6.65 Million | 173.22 Million | 3.78 Million | 35.02 Million | 43.89 Million | - |
| Other Financing Activities | 9.29 Million | 180.96 Million | -596 Thousand | 34.11 Million | -1.58 Million | - |
| Accounts receivables | -27.38 Million | -19.93 Million | -7.19 Million | -328 Thousand | -3.63 Million | -7.22 Million |
| Accounts payables | 33.7 Million | 30.45 Million | 7.48 Million | 1.67 Million | 2.97 Million | 4.43 Million |
| Inventory | -9.63 Million | -5.02 Million | -2.82 Million | -91 Thousand | 101 Thousand | - |
| Other working capital | -30.19 Million | -6.5 Million | -101 Thousand | 30.55 Million | 198 Thousand | -1.48 Million |
| Cash at beginning of period | 116.32 Million | 22.03 Million | 77.94 Million | 44.59 Million | 25.77 Million | 48.75 Million |
| Cash at end of period | 123.23 Million | 116.32 Million | 22.03 Million | 77.94 Million | 44.59 Million | 25.77 Million |
| Capital Expenditure | -10.79 Million | -13.86 Million | -1.33 Million | -322 Thousand | -468 Thousand | - |
| Effect of forex changes on cash | -1.67 Million | 299 Thousand | 3.3 Million | -1.63 Million | -95 Thousand | 1.32 Million |
| Net cash flow / Change in cash | 6.9 Million | 94.29 Million | -55.9 Million | 33.34 Million | 18.82 Million | -22.98 Million |
| Free Cash Flow | 13.09 Million | -77.83 Million | -60.66 Million | 1.63 Million | -23.8 Million | -20.74 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 11.68 Million | 19.53 Million | 5.21 Million | -14.32 Million | -33.18 Million | -104.07 Million |
| Depreciation & Amortization | 1.99 Million | 3.63 Million | 6.92 Million | 3.28 Million | 2.65 Million | 5.37 Million |
| Deferred income taxes | - | 42.78 Million | -8.78 Million | - | 16.88 Million | -13.37 Million |
| Stock-based compensation | - | 7.47 Million | 8.78 Million | 1.31 Million | 5.84 Million | 8.11 Million |
| Change in working capital | - | -57.53 Million | -33.5 Million | - | -28.64 Million | -1 Million |
| Other non-cash items | 23.92 Million | -5.26 Million | 45.25 Million | 30.86 Million | 32.09 Million | 41 Million |
| Investing Cash Flow | -36.92 Million | -22.6 Million | -25.48 Million | -2.88 Million | -5.66 Million | -16.99 Million |
| Investments in PPE | -13.69 Million | -7.78 Million | -10.79 Million | -3 Million | -4.66 Million | -13.86 Million |
| Acquisitions | -23.18 Million | -123 Thousand | - | 123 Thousand | -973 Thousand | -973 Thousand |
| Investment purchases | 4000.00 | -13.15 Million | -13.15 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -49 Thousand | -1.54 Million | -1.54 Million | - | -25 Thousand | -2.16 Million |
| Financing Cash Flow | 3.61 Million | 5.48 Million | 10.18 Million | 4.7 Million | 3.78 Million | 174.96 Million |
| Debt repayment | -1.06 Million | -3.27 Million | -5.75 Million | -2.48 Million | -3.01 Million | -3 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -7.81 Million |
| Common Stock Issuance | 3.29 Million | 3.72 Million | 6.65 Million | 2.92 Million | 1.62 Million | 173.22 Million |
| Other Financing Activities | - | 5.48 Million | 9.29 Million | 2.92 Million | 3.78 Million | 180.96 Million |
| Accounts receivables | - | -27.38 Million | -27.38 Million | - | -19.93 Million | -19.93 Million |
| Accounts payables | - | - | 33.7 Million | - | - | 30.45 Million |
| Inventory | - | -9.63 Million | -9.63 Million | - | -5.02 Million | -5.02 Million |
| Other working capital | - | -20.51 Million | -30.19 Million | - | -3.68 Million | -6.5 Million |
| Cash at beginning of period | 122.7 Million | 131.72 Million | 116.32 Million | 116.32 Million | 122.6 Million | 22.03 Million |
| Cash at end of period | 118.83 Million | 123.23 Million | 123.23 Million | 131.72 Million | 116.32 Million | 116.32 Million |
| Capital Expenditure | -13.69 Million | -7.78 Million | -10.79 Million | -3 Million | -4.66 Million | -13.86 Million |
| Effect of forex changes on cash | - | -1.99 Million | -1.67 Million | 326 Thousand | -655 Thousand | 299 Thousand |
| Net cash flow / Change in cash | -3.87 Million | -8.49 Million | 6.9 Million | 15.4 Million | -6.27 Million | 94.29 Million |
| Free Cash Flow | 19.91 Million | 2.84 Million | 13.09 Million | 10.25 Million | -8.41 Million | -77.83 Million |
TRH1V
BRAGF
0553
9880
A7A
CORE